Breaking
$42M total funding raised through Dec 2024 Series B 78,000 prescription switches in one year $29M in member savings generated 93% of drug switches stay switched at 12 months 4.2x average client lifetime ROI 80+ employer & health-plan clients 17,000 medicines mapped by Med Mapper $42M total funding raised through Dec 2024 Series B 78,000 prescription switches in one year $29M in member savings generated 93% of drug switches stay switched at 12 months 4.2x average client lifetime ROI 80+ employer & health-plan clients 17,000 medicines mapped by Med Mapper
Scripta Insights logo
Company · Health · SaaS · AI

Scripta Insights

"The Right Meds at The Best Price."

A doctor-founded healthtech in Needham, Massachusetts that helps self-insured employers, health plans and their members cut pharmacy benefit costs - without firing their PBM.

Founded 2019 Needham, MA Series B · $42M ~72 employees

Scripta Insights - Rx Navigation company - photographed as its corporate mark, Needham, Massachusetts.

0
Rx switches / year
$29M
Member savings
0
Switches that stick
4.2x
Client lifetime ROI
The Dispatch

Making the pharmacy bill legible

American pharmacy pricing is famously opaque: the same pill can carry five different prices depending on plan, pharmacy and pathway, and the person holding the prescription is usually the last to find out. Scripta Insights was built to close that gap. The company's Rx Navigation platform sits on top of an employer's or health plan's existing pharmacy benefit manager, reads the monthly claims, and surfaces lower-cost, clinically equivalent options that members - and their prescribers - can actually act on.

The pitch to a benefits leader is unusually simple. Keep your PBM. Keep your formulary. Let Scripta reveal where the savings already hide. In a single recent year the company says it drove 78,000 prescription switches and roughly $29 million in savings, and that 93% of those switches were still in place a year later - a durability number that matters more than any one-time discount.

A doctor's problem, a company's mission

The origin story is clinical, not commercial. Co-founder Dr. Paul Bradley, an internist and clinical-trial investigator, kept running into the same wall in the exam room: patients who couldn't afford the medications he prescribed. He teamed with Eric Levin - a serial entrepreneur who had helped grow The Learning Company from $60 million to $1.2 billion before its $3.6 billion sale to Mattel - and in 2019 the two launched Scripta to put prescription choice back in patients' hands.

"We are changing the way people shop for prescription drugs in America - and 93 percent of the switches our clinical recommendations drive stay switched even after 12 months."
Eric Levin - Co-Founder & CEO, Scripta Insights
Who It Serves

Customers, and the problem they carry

Scripta's customers are the organizations that write the checks for drug coverage: self-insured employers ranging from 3,000-life companies to the Fortune 500, along with health plans. More than 80 clients are active today, and the company reaches them through five of the top seven benefits brokers in the United States - a distribution engine that lets a relatively small firm punch well above its headcount.

The problem those customers carry is structural. Pharmacy spend is one of the fastest-rising lines in any benefits budget, and the arrival of blockbuster GLP-1 drugs has turned a slow leak into a flood. Traditional cost control means changing PBMs, tightening formularies, or shifting cost to members - each disruptive, each politically fraught. Scripta's wager is that a large share of savings can be captured without any of that, simply by making the existing options visible.

Segment

Self-insured employers

From ~3,000 lives to Fortune 500, seeking pharmacy savings without a benefits overhaul.

Segment

Health plans

Payers embedding Rx navigation to lower total cost of care for members.

Segment

Brokers & consultants

Five of the top seven U.S. benefits brokers distribute Scripta to their books.

The Toolkit

Products & services

Scripta describes itself as "the Rx Navigation company," and its product line runs from the member's phone to the prescriber's screen to the plan sponsor's dashboard. At the center is Med Mapper, a proprietary, AI-driven clinical database that maps roughly 17,000 medicines to cost-efficient alternatives - the engine that turns a claims file into a savings recommendation.

Members · 2019

Rx Navigator

Personalized savings reports delivered by app, web and mail, revealing every affordable option.

AI Engine · 2019

Med Mapper

Clinical database mapping ~17,000 medicines to lower-cost, therapeutically equivalent choices.

Plan Sponsors · 2019

Rx Monitor

Analytics that benchmark pharmacy spend against PBM contracts and flag optimization.

Engine · 2020

Savings Mapper

Recommendation engine that finds patient-specific savings inside claims data.

Prescribers · 2025

Provider Navigator

Point-of-care visibility into cost-saving options for the clinician writing the script.

Compliance · 2025

Fiduciary Protection Program

Helps self-insured employers meet ERISA duties on prescription-drug pricing.

By The Numbers

Why the switches stick

Discount cards are easy to hand out and easy to abandon. Scripta's differentiator is durability - savings that survive because the recommendation is clinically governed and the member understood the choice. The bars below track the outcomes the company reports.

Switch retention at 12 months93%
2024 revenue growth100%+
Top-7 U.S. brokers partnered5 of 7
Member copay example: $1,200 → $150~88% cut
The Position

How it differs, and where it fits

The pharmacy cost-containment field is crowded with navigation vendors, transparency-minded PBMs and consumer discount apps. Scripta's distinguishing bet is the overlay model: it does not ask a client to rip out and replace its pharmacy benefit manager. It layers on top, adds visibility, and lets savings flow without a disruptive migration. That lowers the switching cost for buyers and puts Scripta alongside - rather than against - the incumbent PBM.

Its second edge is clinical governance. Recommendations are framed as evidence-based medication selection rather than marketing-driven substitution, a stance reinforced by the "doctor founded, doctor driven" culture and the physician co-founder in the C-suite. Integrations with cash-pay pathways such as Mark Cuban Cost Plus Drug Company and SingleCare, plus 2026 partnerships with RxUtility and Quantum Health, widen the set of options the platform can surface.

The business model

Scripta is a B2B SaaS company. It sells the Rx Navigation platform to employers, health plans and consultants - typically on a per-member subscription or performance basis - and grows largely through the broker channel. Revenue grew more than 100% in 2024, and third-party sources estimate annual revenue in the $25M-$50M range, though the company has not published exact figures.

"Scripta provides an unprecedented, clear line of sight into drug spend with actionable solutions for clients to manage benefit design and dramatically reduce spend."
Denise Cabrera - National Pharmacy Practice Lead, McGriff
The Record

A timeline

2019

Scripta Insights founded

Eric Levin and Dr. Paul Bradley launch the company to attack prescription-drug affordability.

2022

Institutional capital

Scripta raises its first major funding round, building toward a $42M total.

2024

Revenue doubles

Revenue grows more than 100% as the client base expands past 80 employers and plans.

2024

$17M Series B

Aquiline Capital Partners leads a December Series B, bringing total funding to $42M.

2025

Provider Navigator & Fiduciary Protection

Scripta extends to prescribers and adds an ERISA compliance program for employers.

2026

Quantum Health & RxUtility

Scripta embeds its savings technology into major navigation and pricing-intelligence platforms.

Reader Questions

FAQ

What does Scripta Insights do?
It runs a pharmacy-benefit navigation and analytics platform that helps self-insured employers, health plans and their members find lower-cost, clinically equivalent prescription options and reduce pharmacy spend.
Does Scripta replace a company's PBM?
No. Scripta layers on top of a client's existing pharmacy benefit manager, adding transparency and savings recommendations without requiring a benefits overhaul.
Who founded Scripta Insights and when?
It was founded in 2019 by CEO Eric Levin and Chief Medical Officer Dr. Paul Bradley, and is headquartered in Needham, Massachusetts.
How much funding has Scripta raised?
Scripta has raised $42 million in total, including a $17 million Series B in December 2024 led by Aquiline Capital Partners.
What results does Scripta report?
The company reports 78,000 prescription switches and roughly $29 million in member savings in a single year, a 93% switch-retention rate at 12 months, and an average 4.2x client lifetime ROI.
Scripta Insights · 117 Kendrick St, Needham, MA 02494 · Profile compiled from public sources. Figures are company-reported or third-party estimates and may be approximate.